176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
2.25%
Cash & equivalents yoy growth below half of MRVL's 18.47%. Michael Burry would question if the firm faces a liquidity squeeze. Check for rising debts or negative cash flow.
14.10%
Higher Short-Term Investments Growth compared to MRVL's zero value, indicating better performance.
9.56%
Cash + STI yoy 0.5-0.75x MRVL's 18.47%. Martin Whitman would worry about lagging short-term reserves. Confirm debt coverage.
15.63%
Similar receivables growth to MRVL's 15.10%. Walter Schloss would see comparable credit policies, investigating any subtle differences in sales.
-14.68%
Inventory growth below half of MRVL's 3.83%. David Dodd would check if that's due to efficiency or supply constraints.
No Data
No Data available this quarter, please select a different quarter.
7.29%
Below half of MRVL's 15.26%. Michael Burry could suspect a liquidity squeeze. Verify operational performance.
-3.02%
0.5-0.75x MRVL's -4.99%. Martin Whitman might see a risk of falling behind in asset investment or shifting strategy.
No Data
No Data available this quarter, please select a different quarter.
-4.75%
Less than half of MRVL's -10.31%. David Dodd sees relatively fewer intangible expansions. Possibly more tangible-driven.
-1.32%
1.1-1.25x MRVL's -1.17%. Bill Ackman might question if intangible expansions are riskier than competitor's approach.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-5.84%
Above 1.5x MRVL's -3.40%. Michael Burry warns of potential hidden liabilities or intangible bloat.
-2.38%
1.25-1.5x MRVL's -1.78%. Bruce Berkowitz checks if expansions surpass competitor's pace but remain justified.
No Data
No Data available this quarter, please select a different quarter.
3.77%
0.75-0.9x MRVL's 4.51%. Bill Ackman questions if competitor invests more aggressively for growth.
22.05%
Less than half of MRVL's 60.81%. David Dodd sees a more disciplined AP approach or lower volume.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
26.94%
Above 1.5x MRVL's 14.45%. Michael Burry sees a red flag for liquidity risk vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1.75%
Less than half of MRVL's 7.66%. David Dodd notes more conservative expansions in non-current obligations.
1.28%
Less than half of MRVL's 7.28%. David Dodd sees a more conservative approach to non-current liabilities.
No Data
No Data available this quarter, please select a different quarter.
22.23%
Above 1.5x MRVL's 12.77%. Michael Burry sees a potential leverage warning sign.
0.31%
50-75% of MRVL's 0.57%. Bruce Berkowitz notes minimal new equity relative to competitor.
-5.97%
Below half MRVL's 8.93%. Michael Burry suspects major net losses or high dividends vs. competitor.
75.83%
Similar yoy to MRVL's 74.89%. Walter Schloss sees parallel comprehensive income changes.
No Data
No Data available this quarter, please select a different quarter.
-3.08%
Below half MRVL's 2.98%. Michael Burry sees potential underperformance in building shareholder capital.
3.77%
0.75-0.9x MRVL's 4.51%. Bill Ackman wonders if competitor invests or leverages more aggressively.
14.10%
Below half MRVL's -0.81%. Michael Burry suspects major underinvestment or forced divestment.
-1.15%
Higher Total Debt Growth compared to MRVL's zero value, indicating worse performance.
-2.42%
Less than half of MRVL's -18.47%. David Dodd sees better deleveraging or stronger cash buildup than competitor.
